Chemical Compound

Ubiquinone Q9; Ubiquinone 9; CoQ9; NSC 226993; 2,3-dimethoxy-5-methyl-6-[(2E,6E,10E,14E,18E,22E,26E,30E)-3,7,11,15,19,23,27,31,35-nonamethyl-2,6,10,14,18,22,26,30,34-hexatriacontanonaen-1-yl]-2,5-Cyclohexadiene-1,4-dione; Coenzyme Q9; 2,3-dimethoxy-5-methyl-6-(3,7,11,15,19,23,27,31,35-nonamethyl-2,6,10,14,18,22,26,30,34-hexatriacontanonaenyl)-p-Benzoquinone; Ubidecarenone EP impurity D

CAS Registry Number 303-97-9
返回搜索 申请报价
Ubiquinone Q9; Ubiquinone 9; CoQ9; NSC 226993; 2,3-dimethoxy-5-methyl-6-[(2E,6E,10E,14E,18E,22E,26E,30E)-3,7,11,15,19,23,27,31,35-nonamethyl-2,6,10,14,18,22,26,30,34-hexatriacontanonaen-1-yl]-2,5-Cyclohexadiene-1,4-dione; Coenzyme Q9; 2,3-dimethoxy-5-methyl-6-(3,7,11,15,19,23,27,31,35-nonamethyl-2,6,10,14,18,22,26,30,34-hexatriacontanonaenyl)-p-Benzoquinone; Ubidecarenone EP impurity D 结构式
Primary record

Ubiquinone Q9; Ubiquinone 9; CoQ9; NSC 226993; 2,3-dimethoxy-5-methyl-6-[(2E,6E,10E,14E,18E,22E,26E,30E)-3,7,11,15,19,23,27,31,35-nonamethyl-2,6,10,14,18,22,26,30,34-hexatriacontanonaen-1-yl]-2,5-Cyclohexadiene-1,4-dione; Coenzyme Q9; 2,3-dimethoxy-5-methyl-6-(3,7,11,15,19,23,27,31,35-nonamethyl-2,6,10,14,18,22,26,30,34-hexatriacontanonaenyl)-p-Benzoquinone; Ubidecarenone EP impurity D

库存
8,292 克
纯度
98.3 %
CAS
303-97-9

化合物标识与属性

CAS
303-97-9
PubChem CID
5280473
SMILES
CC1=C(C(=O)C(=C(C1=O)OC)OC)C/C=C(\C)/CC/C=C(\C)/CC/C=C(\C)/CC/C=C(\C)/CC/C=C(\C)/CC/C=C(\C)/CC/C=C(\C)/CC/C=C(\C)/CCC=C(C)C
Canonical SMILES
COC1=C(OC)C(=O)C(C/C=C(\C)CC/C=C(\C)CC/C=C(\C)CC/C=C(\C)CC/C=C(\C)CC/C=C(\C)CC/C=C(\C)CC/C=C(\C)CCC=C(C)C)=C(C)C1=O

名称与同义词

  • Coenzyme Q9
  • Ubiquinone 9
  • Ubiquinone-9
  • Ubiquinone 45
  • Ubiquinone Q9
  • CoQ9
  • Ubiquinone-45
  • 303-97-9
  • ubiquinone Q-9
  • Coenzyme Q(sub 9)
  • Ubiquinone9
  • Ubiquinone Q(sub 9)
  • CoQ(sub 9)
  • coenzyme-Q9
  • ubiquinone(9)
  • Coenzyme Q(9)
  • Coenzyme Q9?
  • MGW7TYF2DQ
  • COENZYMEQ9
  • UNII-MGW7TYF2DQ
  • AC1NQX2M
  • Coenzyme Q9 (Standard)
  • RefChem:127404
  • Ubidecarenone EP Impurity D
  • DTXSID601317880
  • MFCD00056635
  • Ubidecarenone impurity D CRS
  • UBIQUINONE Q9 (STN)
  • C54H82O4
  • CHEBI:18160
  • UUGXJSBPSRROMU-WJNLUYJISA-N
  • orb1301680
  • CHEMBL2252965
  • Coenzyme Q9 from Candida utilis
  • NSC 226993
  • NSC-226993
  • SCHEMBL27472926
  • Ubidecarenone Related Compound A
  • BRN 1900081
  • DTXCID60909085
  • Ubiquinone Q9;CoQ9;Ubiquinone 9
  • ZINC8217487
  • EX-A14857
  • LMPR02010004
  • MSK158298
  • NSC226993
  • AKOS027307694
  • C54-H82-O4
  • CID5280473
  • Coenzyme Q9, >=96.0% (HPLC)
  • CS-6359
  • EBC-106040
  • FC20538
  • HY-101415R
  • Ubidecarenone Impurity 1(Coenzyme Q9)
  • CID:5280473
  • AS-77794
  • J11.404I
  • LS-40351
  • SID:87225397
  • SY074807
  • HY-101415
  • FT-0665153
  • ubiquinone 9, (Z,Z,Z,Z,Z,E,E,E)-isomer
  • 4-08-00-03313 (Beilstein Handbook Reference)
  • Coenzyme Q9, 99.8% - 100MG 100mg
  • J1.205.858F
  • UBIDECARENONE IMPURITY D [EP IMPURITY]
  • C01967
  • C030571
  • F787628
  • UBIDECARENONE RELATED COMPOUND A [USP-RS]
  • 2,3-Dimethoxy-5-methyl-6-((2E,6E,10E,14E,18E,22E,26E,30E)-3,7,11,15,19,23,27,31,35-nonamethylhexatriaconta-2,6,10,14,18,22,26,30,34-nonaen-1-yl)cyclohexa-2,5-diene-1,4-dione
  • 2,3-dimethoxy-5-methyl-6-[(2E,6E,10E,14E,18E,22E,26E,30E)-3,7,11,15,19,23,27,31,35-nonamethylhexatriaconta-2,6,10,14,18,22,26,30,34-nonaenyl]cyclohexa-2,5-diene-1,4-dione
  • A1025684
  • 2-methyl-3-nonaprenyl-5,6-dimethoxy-1,4-benzoquinone
  • Q27102857
  • 2,3-dimethoxy-5-methyl-6-[(2E,6E,10E,14E,18E,22E,26E,30E)-3,7,11,15,19,23,27,31,35-nonamethylhexatriaconta-2,6,10,14,18,22,26,30,34-nonaen-1-yl]cyclohexa-2,5-diene-1,4-dione
  • 2,5-cyclohexadiene-1,4-dione, 2,3-dimethoxy-5-methyl-6-((2E,6E,10E,14E,18E,22E,26E,30E)-3,7,11,15,19,23,27,31,35-nonamethyl-2,6,10,14,18,22,26,30,34-hexatriacontanonaen-1-yl)-
  • B2699-305013
  • 2,5-Cyclohexadiene-1,4-dione, 2,3-dimethoxy-5-methyl-6-(3,7,11,15,19,23,27,31,35-nonamethyl-2,6,10,14,18,22,26,30,34-hexatriacontanonaenyl)-, (all-E)-
  • p-Benzoquinone, 2,3-dimethoxy-5-methyl-6-(3,7,11,15,19,23,27,31,35-nonamethyl-2,6,10,14,18,22,26,30,34-hexatriacontanonaenyl)-
  • p-Benzoquinone, 2,3-dimethoxy-5-methyl-6-(3,7,11,15,19,23,27,31,35-nonamethyl-2,6,10,14,18,22,26,30,34-hexatriacontanonaenyl)- (VAN)
  • Ubidecarenone impurity D, European Pharmacopoeia (EP) Reference Standard
  • Ubidecarenone Related Compound A, United States Pharmacopeia (USP) Reference Standard
  • (all-E)-2,3-Dimethoxy-5-methyl-6-(3,7,11,15,19,23,27,31,35-nonamethyl-2,6,10,14,18,22,26,30,34-hexatriacontanonaenyl)-2,5-cyclohexad iene-1,4-dione
  • (all-E)-2,3-dimethoxy-5-methyl-6-(3,7,11,15,19,23,27,31,35-nonamethyl-2,6,10,14,18,22,26,30,34-hexatriacontanonaenyl)-2,5-cyclohexadiene-1,4-dione
  • 2,3-dimethoxy-5-methyl-6-((2E,6E,10E,14E,18E,22E,26E,30E)-3,7,11,15,19,23,27,31,35-nonamethylhexatriaconta-2,6,10,14,18,22,26,30,34-nonaenyl)cyclohexa-2,5-diene-1,4-dione
  • 2,3-Dimethoxy-5-methyl-6-(3,7,11,15,19,23,27,31,35-nonamethylhexatriaconta-2,6,10,14,18,22,26,30,34-nonaen-1-yl)cyclohexa-2,5-diene-1,4-dione
  • 2,3-Dimethoxy-5-methyl-6-[(2E,6E,10E,14E,18E,22E,26E,30E)-3,7,11,15,19,23,27,31,35-nonamethyl-2,6,10,14,18,22,26,30,34-hexatriacontanenonenyl]-2,5-cyclohexadiene-1,4-dione
  • 2,3-dimethoxy-5-methyl-6-[(2E,6E,10E,14E,18E,22E,26E,30E)-3,7,11,15,19,23,27,31,35-nonamethylhexatriaconta-2,6,10,14,18,22,26,30,34-nonaen-1-yl]-1,4-benzoquinone
  • 2,3-dimethoxy-5-methyl-6-[(2E,6E,10E,14E,18E,22E,26E,30E)-3,7,11,15,19,23,27,31,35-nonamethylhexatriaconta-2,6,10,14,18,22,26,30,34-nonaenyl]-1,4-benzoquinone
  • 2,3-Dimethoxy-5-methyl-6-[(2E,6E,10E,14E,18E,22E,26E,30E)-3,7,11,15,19,23,27,31,35-nonamethylhexatriaconta-2,6,10,14,18,22,26,30,34-nonene-1-yl]-2,5-cyclohexadiene-1,4-dione
  • 2,4-dione, 2,3-dimethoxy-5-methyl-6-(3,7,11,15,19,23,27,31,35-nonamethyl-2,6,10,14,18,22,26,30,34-hexatriacontanonaenyl)-, (all-E)-
  • 2-[(2E,6E,10E,14E,18E,22E,26E,30E)-3,7,11,15,19,23,27,31,35-Nonamethyl-2,6,10,14,18,22,26,30,34-hexatriacontanonenyl]-5,6-dimethoxy-3-methyl-2,5-cyclohexadiene-1,4-dione
  • 3-Methyl-5,6-dimethoxy-2-(3,7,11,15,19,23,27,31,35-nonamethyl-2,6,10,14,18,22,26,30,34-hexatriacontanonene-1-yl)-1,4-benzoquinone
  • p-Benzoquinone,3-dimethoxy-5-methyl-6-(3,7,11,15,19,23,27,31,35-nonamethyl-2,6,10,14,18,22,26,30,34-hexatriacontanonaenyl)-
  • Q-9
  • Ubiquinone Q9; Ubiquinone 9; CoQ9; NSC 226993; 2,3-dimethoxy-5-methyl-6-[(2E,6E,10E,14E,18E,22E,26E,30E)-3,7,11,15,19,23,27,31,35-nonamethyl-2,6,10,14,18,22,26,30,34-hexatriacontanonaen-1-yl]-2,5-Cyclohexadiene-1,4-dione; Coenzyme Q9; 2,3-dimethoxy-5-methyl-6-(3,7,11,15,19,23,27,31,35-nonamethyl-2,6,10,14,18,22,26,30,34-hexatriacontanonaenyl)-p-Benzoquinone; Ubidecarenone EP impurity D